Navigation Links
FDA Wants to Relax Approval Process for Alzheimer's Drugs
Date:3/14/2013

THURSDAY, March 14 (HealthDay News) -- In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for the memory-robbing disease.

In a proposal published online in the March 14 issue of the New England Journal of Medicine, the FDA said clinical trials of people in the early stages of Alzheimer's would only need to show improvement in tests of thinking and memory. Among these patients, who are only starting to show subtle mental declines, improvements in daily functioning would not have to be seen, The New York Times reported.

The FDA's goal is to speed development of drugs to treat a disease that has no cure, so that the millions of aging baby boomers at risk for Alzheimer's might be able to prevent or slow the degenerative disease. The FDA is taking comments on the proposal, and will possibly make revisions, but the plan is going forward, agency officials said.

Drug companies would still be required to do post-marketing studies on any approved drugs, to confirm their benefits and safeguard against any potential harms from long-term use of these medications.

More than 5 million Americans are living with Alzheimer's, according to the Alzheimer's Association, which translates into one in eight seniors.

And those numbers are expected to swell in the next 20 years, according to the U.S. National Institute on Aging (NIA). The 65-and-older population is expected to double to about 72 million in two decades, and the number of people with Alzheimer's doubles for every five-year interval past age 65, studies have shown. The number of the very elderly, age 85 and older, is estimated to triple by 2050, the NIA added.

More information

For more on Alzheimer's disease, go to the U.S. National Library of Medicine.

-- HealthDay staff

SOURCES: March 14, 2013, New England Journal of Medicine; The New York Times


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. We are Empowered: Alicia Keys Wants to Change the Way Women Think About HIV
2. Kettlebells Expert Lorna Kleidman Wants You to Relive Your Workout and Stay Honest
3. Relaxintuit.com Now Provides Christmas Stress Relief Tips and Gift Ideas for Moms & Dads of All Ages, from Award-Winning Stress Management Expert Susie Mantell
4. Best Christmas Gift for 2012: Instant Stress Relief on CD! Relaxintuit.com’s Award-Winning Meditation CD Soothes Anxiety, Depression, Pain & Supports Deep, Healthy Sleep
5. Cataract Patients Relax to a Soothing Beat, Study Says
6. Massachusetts' Deval Patrick Wins "Green Governor of the Year Award" -- First State to Win Federal Approval for Offshore Wind Farms says BE
7. 'LKLiveMapping' Improves Laboratory Operating Efficiency, Delivers a High First-Submission Approval of Claims, and Improves Collection
8. Test for hormone-disrupting chemicals gets global seal of approval
9. North American Seminars Receives Florida Continuing Education Course Approval for Utilizing Pilates to Enhance Rehab Outcomes an Online/DVD PT Continuing Education Course
10. Meningitis A vaccine breaks barrier; first to gain approval to travel outside cold chain
11. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: